Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Institutes, Companies Form Business to Bridge Discovery Gap

Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials. . . . → Read More: Institutes, Companies Form Business to Bridge Discovery Gap

Foundation Medicine, Sarah Cannon Partner on Cancer Trials

Foundation Medicine, a cancer diagnostics company, and Sarah Cannon Research Institute plan to apply genomic testing of patients’ tumors in clinical trials of personalized treatments. . . . → Read More: Foundation Medicine, Sarah Cannon Partner on Cancer Trials

Biotech, Univ of Miami Spin-Off Vaccine Company

Biotechnology company Heat Biologics Inc. is licensing research from University of Miami in Florida to develop vaccines against infectious diseases, starting with the Zika virus, in a new subsidiary. . . . → Read More: Biotech, Univ of Miami Spin-Off Vaccine Company

Preventive Drugs Offer No Benefit for Children’s Migraine

A clinical trial testing drugs for depression and seizures, but sometimes prescribed to prevent migraines, shows the drugs to be no better than a placebo in preventing migraines among children. . . . → Read More: Preventive Drugs Offer No Benefit for Children’s Migraine

Organ Chip System Designed to Simulate Smoking Effects

A system that combines human airway tissue on a chip with components that simulate cigarette smoking is being developed to test treatments for lung disorders. . . . → Read More: Organ Chip System Designed to Simulate Smoking Effects

Skin Patch Shown to Increase Peanut Tolerance in Children

A skin patch worn by children with peanut allergies was shown in a clinical trial to increase the wearers’ tolerance for peanuts by 10 times after 1 year. . . . → Read More: Skin Patch Shown to Increase Peanut Tolerance in Children

Engineered Mosquito Production Facility Opens

A new industrial lab to produce mosquitoes genetically engineered to prevent the spread of infectious diseases opened in Piracicaba, Brazil. . . . → Read More: Engineered Mosquito Production Facility Opens

Trial to Test Drug Combination for Hospital Infections

A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities. . . . → Read More: Trial to Test Drug Combination for Hospital Infections

ALS Soy Peptide Trial Completes Enrollment

A clinical trial testing a peptide found in soy as a potential treatment for amyotrophic lateral sclerosis or ALS completed its enrollment of 50 participants. . . . → Read More: ALS Soy Peptide Trial Completes Enrollment

Google Acquires Visual Interaction Tech Company

Google is acquiring Eyefluence Inc., developer of a technology that allows individuals to interact with computers, phones, and other devices using only their eyes. . . . → Read More: Google Acquires Visual Interaction Tech Company